The “Optimizing Immuno-Oncology: Innovations in ICI Delivery,” organized by the Binaytara Foundation, is an accredited continuing education activity tailored for oncology providers, including medical oncologists, fellows, advanced practice providers, pharmacists and nurses. Designed to address evolving approaches in immune checkpoint inhibitor (ICI) administration, the program focuses on both intravenous (IV) and subcutaneous (SC) delivery methods across multiple tumor types. Available as a live webinar, recorded webcast, and gamified activity on the Oncoblast app, this program provides healthcare providers with insights into integrating SC ICI administration into practice, selecting appropriate treatment plans, and managing adverse events effectively. Emphasizing a multidisciplinary approach, participants will gain practical tools to improve clinic efficiency, patient adherence, and safety, enhancing patient outcomes in immuno-oncology.
- Provider:Binaytara Foundation
- Activity Link: https://education.binayfoundation.org/node/2451
- Start Date: 2025-03-01 06:00:00
- End Date: 2025-03-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- Commercial Support: No
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence
- Provider Ship: Directly Provided
- Registration: Open to all